03.04.2017 | News
Berlin, Germany — April 3, 2017— SOMATEX® Medical Technologies GmbH today announced a distribution partnership agreement with Hologic, Inc., a leading provider of
medical imaging systems, effective immediately. Hologic will add selected SOMATEX Tumark® biopsy site markers to its world-class portfolio of innovative, award-winning breast cancer screening and interventional products.
“We are proud to partner with a company of Hologic’s caliber. This agreement is an important milestone in our strategy to become a leader in bringing tissue marker technologies to market.” commented André Cerbe Managing Director of SOMATEX.
The agreement includes exclusive distribution rights for the Tumark Professional X, Q, Vision and Flex markers and application devices for the United States. The markers are made of a non-resorbing nitinol material that expands into a distinct marker shape upon deployment into the breast, and are visible in ultrasound, mammography and MRI imaging modalities.
“We are truly excited to market our latest marker technology with such an extraordinary team who shares our passion for bringing products to market that make a real difference to people’s lives.” said SOMATEX’s Business Development Director Joerg Heise.
+49 30 319 8225-39